Browsing by Author "Danese, Silvio"
Now showing items 1-8 of 8
-
Article
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
Bonovas, Stefanos; Fiorino, Gionata; Allocca, Mariangela; Lytras, Theodoros; Nikolopoulos, Georgios K.; Peyrin-Biroulet, L.; Danese, Silvio (2016)Background & Aims Safety issues are a major concern for patients considering treatments for inflammatory bowel disease (IBD). We performed a systematic review and meta-analysis to determine whether biologic agents affect ...
-
Article
Comparative assessment of budesonide-MMX and mesalamine in active, mild-to-moderate ulcerative colitis: A systematic review and network meta-analysis
Bonovas, Stefanos; Nikolopoulos, Georgios K.; Piovani, Daniele; González‐Lorenzo, Marien; Pantavou, Katerina; Lytras, Theodore; Peyrin‐Biroulet, Laurent; Danese, Silvio (2019)Aims The comparative efficacy, safety and tolerability of budesonide-MMX and oral mesalamine in active, mild-to-moderate ulcerative colitis (UC) are unclear. We conducted a network meta-analysis to fill this evidence gap. ...
-
Article
Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis
Bonovas, Stefanos; Nikolopoulos, Georgios K.; Lytras, Theodore; Fiorino, Gionata; Peyrin‐Biroulet, Laurent; Danese, Silvio (2018)Aims Oral systemic corticosteroids have been used to induce remission in patients with active inflammatory bowel disease (IBD) for over 50 years
-
Article
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer—authors’ reply
Bonovas, Stefanos; Fiorino, Gionata; Lytras, Theodoros; Nikolopoulos, Georgios K.; Peyrin-Biroulet, L.; Danese, Silvio (2017)
-
Article
Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses
Pantavou, Katerina; Yiallourou, Anneza I.; Piovani, Daniele; Evripidou, Despo; Danese, Silvio; Peyrin-Biroulet, Laurent; Bonovas, Stefanos; Nikolopoulos, Georgios K. (2019)BackgroundUlcerative colitis (UC) is an inflammatory disease of the colon and rectum. Treatment options include biologics and tofacitinib.ObjectivesWe aim to summarize the evidence on efficacy and safety of biologics and ...
-
Article
Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses
Piovani, Daniele; Danese, Silvio; Peyrin-Biroulet, Laurent; Nikolopoulos, Georgios K.; Lytras, Theodore; Bonovas, Stefanos (2019)BACKGROUND & AIMS: Multiple environmental factors have been associated with the development of inflammatory bowel diseases (IBDs). We performed an umbrella review of meta-analyses to summarize available epidemiologic ...
-
Article
Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
Bonovas, Stefanos; Pantavou, Katerina; Evripidou, Despo; Bastiampillai, Anan Judina; Nikolopoulos, Georgios K.; Peyrin-Biroulet, Laurent; Danese, Silvio (2018)
-
Article
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease
Bonovas, Stefanos; Fiorino, Gionata; Lytras, Theodoros; Nikolopoulos, Georgios K.; Peyrin-Biroulet, L.; Danese, Silvio (2017)Background: The relationship of 5-aminosalicylates’ use with the risk of colorectal neoplasia in patients with inflammatory bowel disease (IBD) has been the focus of a growing body of research. Aim: To investigate this ...